Proto Labs former officer proposes sale of 1,800 shares
The notice also lists 10,753 common shares sold on August 4, 2026, for $947,786.62 during the preceding three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Proto Labs, Inc. (PRLB) former officer Michael Roy Kenison reported a proposed sale of 1,800 common shares, with an approximate sale date of September 24, 2026, and an aggregate market value of $172,534.50. The shares are listed as acquired from the issuer on that date through exercise of options under a registered plan, with cash payment; Morgan Stanley Smith Barney LLC is named as broker. The notice also reports that Kenison sold 10,753 common shares on August 4, 2026, for $947,786.62 during the preceding three months.
Key Figures
Key Terms
Rule 144 regulatory
Exercise of Options Under a Registered Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.